Covered recipient · General Payments record
STEPHEN G ABSHIRE
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$7,574.17
- Reported across 302 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.41 | 26 |
| Debt forgiveness | $15.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $200.54 | 18 |
| Celgene Corporation | $60.33 | 3 |
| PFIZER INC. | $29.17 | 2 |
| Gilead Sciences, Inc. | $27.27 | 1 |
| Medtronic, Inc. | $15.00 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.32 | 1 |
| Ferring Pharmaceuticals Inc. | $13.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.15 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169978 | CMS |
| ABBVIE INC. | $16.62 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169980 | CMS |
| ABBVIE INC. | $12.27 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169982 | CMS |
| ABBVIE INC. | $18.84 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169984 | CMS |
| ABBVIE INC. | $6.24 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169986 | CMS |
| ABBVIE INC. | $6.12 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169988 | CMS |
| ABBVIE INC. | $18.59 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169990 | CMS |
| ABBVIE INC. | $12.04 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169992 | CMS |
| ABBVIE INC. | $15.36 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169994 | CMS |
| ABBVIE INC. | $16.84 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169996 | CMS |
| ABBVIE INC. | $12.27 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103169998 | CMS |
| ABBVIE INC. | $3.81 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170000 | CMS |
| ABBVIE INC. | $10.94 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170002 | CMS |
| ABBVIE INC. | $9.95 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170004 | CMS |
| ABBVIE INC. | $8.98 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170006 | CMS |
| ABBVIE INC. | $10.03 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170008 | CMS |
| ABBVIE INC. | $6.43 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170010 | CMS |
| ABBVIE INC. | $3.06 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103170012 | CMS |
| Celgene Corporation | $24.93 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101089371 | CMS |
| Celgene Corporation | $15.54 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101089373 | CMS |
| Celgene Corporation | $19.86 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101089375 | CMS |
| Ferring Pharmaceuticals Inc. | $13.78 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137459990 | CMS |
| Gilead Sciences, Inc. | $27.27 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133785097 | CMS |
| Medtronic, Inc. | $15.00 | 12/31/2024 | Debt forgiveness | Undisputed | 01/23/2026 | 1112075508 | CMS |
| PFIZER INC. | $15.19 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131184382 | CMS |
| PFIZER INC. | $13.98 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131863501 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.32 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153605128 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.